Can CA 19-9 predict inferior surgical and pathological outcomes for resectable pancreatic cancer?

被引：0
|
作者：
Jabbal, Iktej Singh
Nagarajan, Arun
Roy, Mayank
Rivera, Carlos
Yaghi, Marita
Liang, Hong
Nguyen, Timmy Q.
George, Tiffany L.
Nahleh, Zeina A.
Simpfendorfer, Conrad H.
机构：
[1] Cleveland Clin Florida, Weston, FL USA
[2] Cleveland Clin, Weston, FL USA
[3] Cleveland Clin Florida, Coral Springs, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16228
引用
收藏
页码：E16288 / E16288
页数：1
相关论文
共 50 条
  • [1] The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer
    Kang, Chang Moo
    Kim, Jun Young
    Choi, Gi Hong
    Kim, Kyung Sik
    Choi, Jin Sub
    Lee, Woo Jung
    Kim, Byong Ro
    JOURNAL OF SURGICAL RESEARCH, 2007, 140 (01) : 31 - 35
  • [2] RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy
    Bold, Richard J.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2108 - 2110
  • [3] RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy
    Richard J. Bold
    Annals of Surgical Oncology, 2013, 20 : 2108 - 2110
  • [4] The role of Ca 19-9 in progression, recurrence and survival of borderline resectable pancreatic cancer
    Almeida, C.
    Goncalves, M.
    Freitas, M.
    Teixeira, C.
    Couto, M.
    Lemos, T.
    Meireles, S.
    Rego, I.
    Sarmento, C.
    Coelho, A.
    Costa, A.
    Barbosa, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S143 - S144
  • [5] Ca 19-9 can predict early response in patients (PTS) with advanced pancreatic cancer (PC)
    Berardi, Rossana
    Squadroni, Michela
    Scartozzi, Mario
    Silva, Rosa Rita
    Mari, Davide
    Massacesi, Cristian
    Pierantoni, Chiara
    Cascinu, Stefano
    ANNALS OF ONCOLOGY, 2006, 17 : 323 - 323
  • [6] Prognostic value of CA 19-9 level in resectable pancreatic adenocarcinoma
    Rudnicki, J.
    Agrawal, A. K.
    Grzebieniak, Z.
    Zukrowski, P.
    Zysko, D.
    Jelen, M.
    Kielan, W.
    Sebastian, M.
    Slonina, J.
    Marek, G.
    Duda-Barcik, L.
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2010, 48 (02) : 249 - 261
  • [7] CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer
    Karachristos, A
    Scarmeas, N
    Hoffman, JP
    JOURNAL OF GASTROINTESTINAL SURGERY, 2005, 9 (09) : 1286 - 1292
  • [8] CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer
    Andreas Karachristos
    Nikolaos Scarmeas
    John P. Hoffman
    Journal of Gastrointestinal Surgery, 2005, 9 : 1286 - 1292
  • [9] Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A retrospective cohort analysis
    Kim, Joon Kyung
    DePeralta, Danielle K.
    Ogami, Takuya
    Denbo, Jason W.
    Pimiento, Jose
    Hodul, Pamela J.
    Malafa, Mokenge P.
    Kim, Dae W.
    Fleming, Jason B.
    Powers, Benjamin D.
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (06) : 1074 - 1083
  • [10] Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
    Kondo, Naru
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Hayashidani, Yasuo
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakashima, Akira
    Sakabe, Ryutaro
    Shigemoto, Norifumi
    Kato, Yasushi
    Ohge, Hiroki
    Sueda, Taijiro
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (09) : 2321 - 2329
12345